{
  "raw_response": "Looking at this clinical presentation systematically:\n\n**Key Clinical Features:**\n- Hypothyroidism (autoimmune disease)\n- Fatigue, lethargy (anemia symptoms)\n- Epigastric pain after eating\n- Pale conjunctivae (anemia)\n- Decreased hemoglobin (anemia)\n- **Increased serum gastrin** (critical finding)\n- Inflammation of gastric body and fundus\n- Biopsy from gastric antrum\n\n**Analysis:**\n\nThe combination of:\n1. **Elevated gastrin** + inflammation of body/fundus strongly suggests **autoimmune atrophic gastritis**\n2. Autoimmune atrophic gastritis involves **parietal cell destruction** by autoantibodies\n3. Loss of parietal cells \u2192 loss of acid production \u2192 loss of negative feedback \u2192 **hypergastrinemia**\n4. Loss of intrinsic factor (from parietal cells) \u2192 B12 deficiency \u2192 megaloblastic anemia (explaining the anemia)\n5. Association with other autoimmune diseases (hypothyroidism) is classic\n\n**Why each option:**\n- **Parietal cell destruction (Option 2)**: This is the PRIMARY pathologic process causing all downstream effects\n- Enterochromaffin-like cell hyperplasia (Option 1): This is a CONSEQUENCE of chronic hypergastrinemia, not the cause\n- Mucosal/Chief cell destruction: Not the primary pathology in autoimmune gastritis\n\nThe question asks for the \"most likely CAUSE\" - parietal cell destruction is the initiating pathologic event that causes the hypergastrinemia, anemia, and other manifestations.\n\n{\"answer_index\": 2, \"answer_text\": \"Parietal cell destruction\", \"confidence\": 9, \"reasoning\": \"Autoimmune atrophic gastritis with parietal cell destruction explains hypergastrinemia, body/fundus inflammation, anemia from B12 deficiency, and association with hypothyroidism. This is the primary pathologic cause, not the secondary ECL hyperplasia.\", \"evidence_quality\": \"normal\"}",
  "model": "claude-sonnet-4.5",
  "usage": {
    "prompt_tokens": 476,
    "completion_tokens": 488
  }
}